GNGT1 and gastric cancer: Our study demonstrated that GNGT1 expression was significantly upregulated in GC and that high GNGT1 expression may be associated with adverse clinical characteristics and clinical outcomes and is a potential biomarker for GC diagnosis and prognosis evaluation.